INTEGRA LIFESCIENCES HOLDINGS CORP Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss)
INTEGRA LIFESCIENCES HOLDINGS CORP (IART) reported Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss) of -$9.30 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Compensation Related Costs › Defined Benefit Plan › Defined Benefit Plan, Roll Forwards
us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation · last filed 2026-02-26
- INTEGRA LIFESCIENCES HOLDINGS CORP defined benefit plan, benefit obligation, foreign currency translation gain (loss) for fiscal 2025 was -$9.30M, a 287.85% decline from fiscal 2024.
- INTEGRA LIFESCIENCES HOLDINGS CORP defined benefit plan, benefit obligation, foreign currency translation gain (loss) for fiscal 2024 was $4.95M.
- INTEGRA LIFESCIENCES HOLDINGS CORP defined benefit plan, benefit obligation, foreign currency translation gain (loss) for fiscal 2023 was -$4.96M, a 373.92% decline from fiscal 2022.
- INTEGRA LIFESCIENCES HOLDINGS CORP defined benefit plan, benefit obligation, foreign currency translation gain (loss) for fiscal 2022 was $1.81M, a 31.88% decline from fiscal 2021.
| Period end | Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss) 12 month | Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss) 12 month as first filed |
|---|---|---|
| 2025-12-31 | -$9.30M 10-K · filed 2026-02-26 | |
| 2024-12-31 | $4.95M 10-K · filed 2026-02-26 | |
| 2023-12-31 | -$4.96M 10-K · filed 2025-02-25 | |
| 2022-12-31 | $1.81M 10-K · filed 2024-02-28 | |
| 2021-12-31 | $2.66M 10-K · filed 2023-02-22 | -$2.66M 10-K · filed 2022-02-24 |
| 2020-12-31 | $6.12M 10-K · filed 2022-02-24 | |
| 2019-12-31 | $639.00K 10-K · filed 2021-02-23 | |
| 2018-12-31 | -$374.00K 10-K · filed 2020-02-21 | |
| 2017-12-31 | -$175.00K 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |